To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
The Yomiuri Shimbun A package of the Kobayashi Pharmaceutical Co.’s supplements in question
Jiji Press
13:27 JST, August 14, 2024
Osaka, Aug. 13 (Jiji Press) — Kobayashi Pharmaceutical Co. said Tuesday it has newly found 11 more fatalities that should have been reported to Japan’s health ministry over possible links to supplement products containing its “beni koji” red fermented rice.
The 11 cases had been classified into a wrong category in the process of sorting out the inquiries made to its call center, the company said, explaining the reason for failing to report them properly.
There was a flaw in the firm’s system to confirm damage reports, Kobayashi Pharmaceutical President Satoshi Yamane said in an online press conference. “We sincerely apologize for this,” he said.
It was later confirmed that five of the 11 victims did not take the supplements in question, according to the company, based in the western Japan city of Osaka.
The remaining six cases, however, will be investigated as their possible links with the intake of the supplements cannot be ruled out, the company said.
Following the revelation in late March of the health hazards caused by the supplements, the company initially said that the number of deaths suspected to be related to consumption of the supplements was five. In late June, 76 more suspected cases were found after the company counted fatal cases stemming from causes other than kidney disease.
After more investigations, the figure for suspected cases has reached 116, including those newly announced Tuesday, according to the company.
